What the Tamiflu saga tells us about drug trials and big pharma

“And so, paradoxically, after everything you have read above, with the outrage fresh in your mind, on the day when it feels harder than any other, I hope you will join me in saying: Bravo, Roche. Now let’s do better.” Ben Goldacre highlights the deficiencies of a regulatory system which governs the approval of pharmaceutical drugs.